UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing

Journal of clinical oncology, 2001-06, Vol.19 (11), p.2875-2882

2001

Volltextzugriff (PDF)

Phase I study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Haematologica (Roma), 2016-07, Vol.101 (7), p.e295-e298

2016

Volltextzugriff (PDF)

Cancer incidence in world trade center rescue and recovery workers, 2001-2008

Environmental health perspectives, 2013-06, Vol.121 (6), p.699-704

2013

Volltextzugriff (PDF)

Treatment of Relapsed Chronic Lymphocytic Leukemia by 72-Hour Continuous Infusion or 1-Hour Bolus Infusion of Flavopiridol: Results from Cancer and Leukemia Group B Study 19805

Clinical cancer research, 2005-06, Vol.11 (11), p.4176-4181

2005

Volltextzugriff (PDF)

Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905

Journal of clinical oncology, 2014-04, Vol.32 (12), p.1242-1248

2014

Volltextzugriff (PDF)

Prospective cohort study of the circadian rhythm pattern in allogeneic sibling donors undergoing standard granulocyte colony-stimulating factor mobilization

Stem cell research & therapy, 2013-03, Vol.4 (2), p.30-30, Article 30

2013

Volltextzugriff (PDF)

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium

The New England journal of medicine, 1988-06, Vol.318 (22), p.1414-1422

1988

Volltextzugriff (PDF)

Azacitidine with or without Entinostat for the treatment of therapy‐related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study

British journal of haematology, 2016-02, Vol.172 (3), p.384-391

2016

Volltextzugriff (PDF)

Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis

The New England journal of medicine, 1989-06, Vol.320 (24), p.1574-1580

1989

Volltextzugriff (PDF)

Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS

British journal of haematology, 2014-10, Vol.167 (1), p.62-68

2014

Volltextzugriff (PDF)

Final results of EFC6663: A multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia

Leukemia research, 2015-05, Vol.39 (5), p.495-500

2015

Volltextzugriff (PDF)

Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide

The New England journal of medicine, 1998-11, Vol.339 (19), p.1341-1348

1998

Volltextzugriff (PDF)

Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity

Leukemia research, 2005-11, Vol.29 (11), p.1253-1257

2005

Volltextzugriff (PDF)

Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks

Cancer, 2007-10, Vol.110 (7), p.1629

2007

Volltextzugriff (PDF)

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

The New England journal of medicine, 1991-05, Vol.324 (20), p.1385-1393

1991

Volltextzugriff (PDF)

A Randomized Controlled Phase III Trial of Recombinant Human Granulocyte Colony-Stimulating Factor (Filgrastim) for Treatment of Severe Chronic Neutropenia

Blood, 1993-05, Vol.81 (10), p.2496-2502

1993

Volltextzugriff (PDF)

Recombinant methionyl human stem cell factor and Filgrastim for peripheral blood progenitor cell mobilization and transplantation in non Hodgkin's lymphoma patients : Results of a phase I/II trial

Blood, 1997-05, Vol.89 (9), p.3136-3147

1997

Volltextzugriff (PDF)

Phospholipase C Release of Basic Fibroblast Growth Factor from Human Bone Marrow Cultures as a Biologically Active Complex with a Phosphatidylinositol-Anchored Heparan Sulfate Proteoglycan

The Journal of cell biology, 1991-09, Vol.114 (6), p.1275-1283

1991

Volltextzugriff (PDF)

Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer

Journal of clinical oncology, 1993-03, Vol.11 (3), p.408-414

1993

Volltextzugriff (PDF)

A Phase I Trial of Recombinant Human Interleukin-1β Alone and in Combination With Myelosuppressive Doses of 5-Fluorouracil in Patients With Gastrointestinal Cancer

Blood, 1991-09, Vol.78 (6), p.1420-1427

1991

Volltextzugriff (PDF)

The acute metabolic effects of tumor necrosis factor administration in humans

Archives of surgery (Chicago. 1960), 1987-12, Vol.122 (12), p.1396

1987

Volltextzugriff (PDF)

A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinoma

Investigational new drugs, 1988-09, Vol.6 (3), p.179-188

1988

Volltextzugriff (PDF)

Expansion of activated T-lymphocytes in patients treated with recombinant interleukin 2

Journal of biological response modifiers, 1987-08, Vol.6 (4), p.412

1987

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Female
(21)
Male
(20)
Middle Aged
(19)
Aged
(17)
Biological And Medical Sciences
(13)
Medical Sciences
(12)
Hematology
(9)
Pharmacology. Drug Treatments
(9)
Aged, 80 And Over
(8)
Oncology
(8)
Treatment Outcome
(8)
Drug Administration Schedule
(7)
Recombinant Proteins - Therapeutic Use
(7)
Chemotherapy
(6)
Antineoplastic Agents
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(5)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing

Phase I study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Cancer incidence in world trade center rescue and recovery workers, 2001-2008

Treatment of Relapsed Chronic Lymphocytic Leukemia by 72-Hour Continuous Infusion or 1-Hour Bolus Infusion of Flavopiridol: Results from Cancer and Leukemia Group B Study 19805

Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905

Prospective cohort study of the circadian rhythm pattern in allogeneic sibling donors undergoing standard granulocyte colony-stimulating factor mobilization

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium

Azacitidine with or without Entinostat for the treatment of therapy‐related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study

Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis

Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS

Final results of EFC6663: A multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia

Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide

Flavopiridol administered as a 24-hour continuous infusion in chronic lymphocytic leukemia lacks clinical activity

Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

A Randomized Controlled Phase III Trial of Recombinant Human Granulocyte Colony-Stimulating Factor (Filgrastim) for Treatment of Severe Chronic Neutropenia

Results of a Randomized Trial Comparing Idarubicin and Cytosine Arabinoside With Daunorubicin and Cytosine Arabinoside in Adult Patients With Newly Diagnosed Acute Myelogenous Leukemia

Recombinant methionyl human stem cell factor and Filgrastim for peripheral blood progenitor cell mobilization and transplantation in non Hodgkin's lymphoma patients : Results of a phase I/II trial

Phospholipase C Release of Basic Fibroblast Growth Factor from Human Bone Marrow Cultures as a Biologically Active Complex with a Phosphatidylinositol-Anchored Heparan Sulfate Proteoglycan

Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer

A Phase I Trial of Recombinant Human Interleukin-1β Alone and in Combination With Myelosuppressive Doses of 5-Fluorouracil in Patients With Gastrointestinal Cancer

The acute metabolic effects of tumor necrosis factor administration in humans

A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinoma

Expansion of activated T-lymphocytes in patients treated with recombinant interleukin 2

Aktive Filter

Suchergebnisse filtern